Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. - Wikidata - wikimedia - TriplyDB

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

http://www.wikidata.org/entity/Q37209082

about

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells Cord Blood as a Source of Natural Killer Cells Umbilical cord blood transplantation for the treatment of hematologic malignancies Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies Biology and clinical effects of natural killer cells in allogeneic transplantation.Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr Natural killer cell mediated missing-self recognition can protect mice from primary chronic myeloid leukemia in vivo.Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Umbilical cord blood transplantation: the first 25 years and beyond.Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood How I treat: the selection and acquisition of unrelated cord blood grafts.Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.Immune Reactions following Cord Blood Transplantations in Adults.T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.Genetics of graft-versus-host disease: the major histocompatibility complex.Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission.Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).Mouse models in bone marrow transplantation and adoptive cellular therapy.Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality?An overview of the progress on double umbilical cord blood transplantation.Use of NK cell activity in cure by transplant.Umbilical cord blood immunology: relevance to stem cell transplantation.Clinical relevance of natural killer cells following hematopoietic stem cell transplantation.At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Gr Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Impact of HLA in cord blood transplantation outcomes.Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.

P2860

Q26751011-38ACD0E1-81D4-4DAC-A30E-4C1F3CEE24DD Q26771337-63886CA7-A435-4B56-A8D0-98A1E19941EB Q26820829-B7EF8920-8305-4512-83CD-D24FA9EE09B1 Q26996660-245EC052-0271-41E8-A44A-ECD49A6F6310 Q33893173-687A5A42-BA50-45CB-9189-8AF935F39A8B Q34033553-99AA2792-52D3-4A87-A81D-462659AF36B8 Q34044024-EE26BFDE-093D-49BE-9D1E-B658AD0D4092 Q34087767-788786E5-90E2-44E3-AE96-AA0ECA596AC3 Q34232835-6489A6D5-BFF9-4DBE-A825-BF21A654EF80 Q34344669-FCE4D195-EBDF-46EC-A871-778A6B8D7E9F Q34374133-9CF282E3-56C4-418F-841E-D790713CB448 Q34707580-EF448338-50AE-487C-B9FC-26C28B02BDD6 Q35034803-F9EE83EB-0F74-46C4-ADEA-5933D0215A6A Q35054475-7D0E1CE2-E28F-4319-B82C-2D811BA66EF7 Q35871747-BE28BA69-88C3-426F-B37B-3E72FF99C7FE Q35958215-E291EA3B-87E2-4323-88BA-E988D6296D63 Q36366949-C6874341-5D5E-4D80-BC0B-850E60E2167A Q36766250-584CF016-87BF-4E41-9B0C-79CF28D3795C Q36775731-2E845A9D-5C82-4A04-89CD-FB89405408E4 Q36999109-3CCB6B3E-77F6-4779-AFDB-D1A523394EFD Q37024340-A69016CC-8931-4ACC-AD32-908BD113D706 Q37415942-E9C00629-AF7F-423B-8B9D-5997B77C395E Q37432020-2BFF4690-DD90-4D7C-988E-E981179D8614 Q37524719-D98CBCA9-ACC9-4FD0-A6D5-B62769F07A71 Q37589671-34D9A0D4-EC21-49FB-B2A8-9A29BE7A6B99 Q37677563-0AB87890-EE7D-4184-BC20-27074A3B43D3 Q37853787-FDEED7B7-CDF4-4C0E-BA37-2CD4F49D6FB4 Q37872506-B1C2ABAA-E1FF-42E2-9427-8E852E7010FC Q37910960-3C0475DF-F457-40F1-A92B-77D236F75F3C Q37963798-31347091-F52E-49EC-9B03-5C9A7BF723CF Q38079585-18763DA5-C70B-4BDB-8368-1776015E6385 Q38149725-8AC0EBA1-AEE1-4628-A588-BF6E52FD69C5 Q38513534-E77CA17C-3E96-4ED5-9C96-11A395587B96 Q38586429-D3C6825B-330D-47E7-838F-FDD94F178272 Q38656322-3779975E-A434-42FE-B1AD-80A8648983B7 Q38666661-25FB8A00-B254-4CD0-981C-2BFA091A59E9 Q38733830-5B764CE8-0AA6-4545-8677-24385CCB9468 Q38747929-094DF47A-F0A7-46A3-9330-07244A3DB9B9 Q38802750-7116E715-FF38-4A51-8CCB-E295A9C8C965 Q39117286-6276CFE3-7C65-41A7-901C-A8947F5EBBA9

P2860

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

http://www.wikidata.org/entity/Q37209082

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Negative effect of KIR allorea ...... tation conditioning intensity.

@en

Negative effect of KIR allorea ...... tation conditioning intensity.

@nl

type

label

Negative effect of KIR allorea ...... tation conditioning intensity.

@en

Negative effect of KIR allorea ...... tation conditioning intensity.

@nl

prefLabel

Negative effect of KIR allorea ...... tation conditioning intensity.

@en

Negative effect of KIR allorea ...... tation conditioning intensity.

@nl

P1433

Q37209082-253AE97D-2960-434A-956B-866BC110090D

P1476

Q37209082-9BD74040-11AF-4166-9184-64D3BB93F79A

P2093

Q37209082-092D5D0E-D5D7-4E41-93BC-56C7B3CB64CE

Q37209082-418FC248-F1D9-474D-9FCB-1ED056EA1E31

Q37209082-5E4C2865-1D17-42FB-A885-BAE2869E0B78

Q37209082-A2781292-D46F-4037-801F-A145A29792BC

Q37209082-AF46BB0F-8BED-4984-937A-606D7E58B17F

Q37209082-BF002592-9047-43E0-A3CF-5C65BDD85C59

Q37209082-E270DB51-5345-4507-B6F3-D183ECF8E221

Q37209082-F406228E-3F88-4C48-B6FD-CC8F6A6CE803

Q37209082-FCA50375-E155-41FD-9E50-31329579C7AA

P2860

Q37209082-05B6A7A7-EB7F-45D4-8F07-A561D365B7AF

Q37209082-06D1BA1A-870E-4C53-964E-654CB390D6AE

Q37209082-11126E2A-0312-4766-AA21-674EC2873847

Q37209082-13794732-EDEE-4BF2-A6C1-E5F0F4815A78

Q37209082-293F1313-F6CC-426D-9720-D1F75B838A60

Q37209082-2FBFF7A0-6095-4055-8D27-F7CFD31C1D61

Q37209082-4511799E-A28A-45DF-9731-B6D2B06342E6

Q37209082-45927B5E-AF09-4DC9-83CA-743286EA4BF3

Q37209082-493489BE-0C09-487C-AA58-64A998356D30

Q37209082-4F8785B1-933D-4029-A45E-D42280582C94

P304

Q37209082-545F9420-3C3A-4F4A-BDB4-689E2FF43314

P31

Q37209082-CAD2BD89-BADD-4AC6-9A6B-096EE0F7C692

P356

Q37209082-5185D03C-3031-4802-BC57-FFB446EE5E87

P407

Q37209082-33325BB6-CA42-4151-BDB8-25C7C07BF048

P433

Q37209082-1AE5F068-7C3E-4759-931C-2BEA39B9A3C3

P478

Q37209082-3070F42A-B7E9-44AC-94C0-A5707FFBBC63

P50

Q37209082-A08EA913-6E20-473B-8CFB-D3516C663BAD

P577

Q37209082-4E1B5AFB-4BE0-4538-8CAA-8EB8184D5BA6

P698

Q37209082-EDFC4566-C6F0-4A1E-8203-76D895E39A6C

P932

Q37209082-29C5CAFD-8CFC-418B-8599-59376DF73B77

P356

BLOOD-2008-12-197467

P1433

P1476

Negative effect of KIR allorea ...... tation conditioning intensity.

@en

P2093

Claudio G Brunstein

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

Harriet Noreen

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Miller

http://www.w3.org/2001/XMLSchema#string

John E Wagner

http://www.w3.org/2001/XMLSchema#string

Juliet N Barker

http://www.w3.org/2001/XMLSchema#string

Michael R Verneris

http://www.w3.org/2001/XMLSchema#string

Sarah Cooley

http://www.w3.org/2001/XMLSchema#string

Todd DeFor

http://www.w3.org/2001/XMLSchema#string

P2860

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Biology of natural killer cells in cancer and infection.

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

P304

5628-5634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-12-197467

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19329778

http://www.w3.org/2001/XMLSchema#string

P932

2689057

http://www.w3.org/2001/XMLSchema#string